anti-PD1/PDL1 antibody

PD-1/PD-L1 inhibitor

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for anti-PD1/PDL1 antibody, covering 2025-01-16 to 2025-01-16. Get the full timeline:

Most recent: Clinical Trial Update: Abraxane With Anti-PD1/PDL1 in Patients With Advanced Urothelial Cancer [Phase 2]